Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
Active, not recruiting · NCT03317405 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, neoplasm, skin disorder | Active, not recruiting | Phase 1 | 2026-09-02 | NCT03317405 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Northwestern University | Chicago | United States | 727 |